{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:39:03Z","timestamp":1786117143518,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 24K11826"],"award-info":[{"award-number":["JP 24K11826"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017744","name":"Japan Surgical Society","doi-asserted-by":"publisher","award":["JSS Young Researcher Award 2019"],"award-info":[{"award-number":["JSS Young Researcher Award 2019"]}],"id":[{"id":"10.13039\/100017744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007697","name":"Northern Advancement Center for Science and Technology","doi-asserted-by":"publisher","award":["Promotion for Young Research Talent and Network 20"],"award-info":[{"award-number":["Promotion for Young Research Talent and Network 20"]}],"id":[{"id":"10.13039\/501100007697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"DOI":"10.1007\/s00595-026-03454-2","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:16:07Z","timestamp":1786022167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative plasma anti-DNAJB8 autoantibody and postoperative outcomes in breast cancer: an exploratory analysis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4672-535X","authenticated-orcid":false,"given":"Daisuke","family":"Kyuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Mizue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reona","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinae","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaka","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira C.","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goro","family":"Kutomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Hirohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Anazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Osanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"3454_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3454_CR2","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149:778\u201389.","journal-title":"Int J Cancer"},{"key":"3454_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejca.2022.05.028","volume":"172","author":"NML Battisti","year":"2022","unstructured":"Battisti NML, Smith IE. Preventing late recurrence in hormone receptor-positive early breast cancer: a review. Eur J Cancer. 2022;172:53\u201364.","journal-title":"Eur J Cancer"},{"key":"3454_CR4","first-page":"168","volume":"60","author":"L Lopez-Gonzalez","year":"2024","unstructured":"Lopez-Gonzalez L, Sanchez Cendra A, Sanchez Cendra C, Roberts Cervantes ED, Espinosa JC, Pekarek T, et al. Exploring biomarkers in breast cancer: Hallmarks of diagnosis, treatment, and follow-up in clinical practice. Med (Kaunas). 2024;60:168.","journal-title":"Med (Kaunas)"},{"key":"3454_CR5","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1158\/1055-9965.EPI-12-0498","volume":"21","author":"Y Sun","year":"2012","unstructured":"Sun Y, Zhang R, Wang M, Zhang Y, Qi J, Li J. SOX2 autoantibodies as noninvasive serum biomarker for breast carcinoma. Cancer Epidemiol Biomarkers Prev. 2012;21:2043\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3454_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cccn.2005.06.009","volume":"362","author":"A Yagihashi","year":"2005","unstructured":"Yagihashi A, Ohmura T, Asanuma K, Kobayashi D, Tsuji N, Torigoe T, et al. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer. Clin Chim Acta. 2005;362:125\u201330.","journal-title":"Clin Chim Acta"},{"key":"3454_CR7","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s13277-014-2756-5","volume":"36","author":"W Liu","year":"2015","unstructured":"Liu W, De La Torre IG, Guti\u00e9rrez-Rivera MC, Wang B, Liu Y, Dai L, et al. Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer. Tumour Biol. 2015;36:1307\u201312.","journal-title":"Tumour Biol"},{"key":"3454_CR8","doi-asserted-by":"publisher","first-page":"982425","DOI":"10.1155\/2011\/982425","volume":"2011","author":"E Piura","year":"2011","unstructured":"Piura E, Piura B. Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma. J Oncol. 2011;2011:982425.","journal-title":"J Oncol"},{"key":"3454_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/cas.12362","volume":"105","author":"R Morita","year":"2014","unstructured":"Morita R, Nishizawa S, Torigoe T, Takahashi A, Tamura Y, Tsukahara T, et al. Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells. Cancer Sci. 2014;105:389\u201395.","journal-title":"Cancer Sci"},{"key":"3454_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/cas.13501","volume":"109","author":"H Kusumoto","year":"2018","unstructured":"Kusumoto H, Hirohashi Y, Nishizawa S, Yamashita M, Yasuda K, Murai A, et al. Cellular stress induces cancer stem-like cells through expression of DNAJB8 by activation of heat shock factor 1. Cancer Sci. 2018;109:741\u201350.","journal-title":"Cancer Sci"},{"key":"3454_CR11","doi-asserted-by":"publisher","first-page":"e0146501","DOI":"10.1371\/journal.pone.0146501","volume":"11","author":"M Yamashita","year":"2016","unstructured":"Yamashita M, Hirohashi Y, Torigoe T, Kusumoto H, Murai A, Imagawa T, et al. Dnajb8, a member of the heat shock protein 40 family has a role in the tumor initiation and resistance to Docetaxel but is dispensable for stress response. PLoS ONE. 2016;11:e0146501.","journal-title":"PLoS ONE"},{"key":"3454_CR12","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1158\/1055-9965.EPI-20-0331","volume":"29","author":"F Rauf","year":"2020","unstructured":"Rauf F, Anderson KS, LaBaer J. Autoantibodies in early detection of breast cancer. Cancer Epidemiol Biomarkers Prev. 2020;29:2475\u201385.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3454_CR13","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","volume":"351","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527.","journal-title":"BMJ"},{"key":"3454_CR14","doi-asserted-by":"publisher","first-page":"e1001216","DOI":"10.1371\/journal.pmed.1001216","volume":"9","author":"DG Altman","year":"2012","unstructured":"Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration. PLoS Med. 2012;9:e1001216.","journal-title":"PLoS Med"},{"key":"3454_CR15","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/cancers17091469","volume":"17","author":"D Kyuno","year":"2025","unstructured":"Kyuno D, Asano H, Okumura R, Takasawa K, Takasawa A, Konno T, et al. The role of claudin-1 in enhancing pancreatic cancer aggressiveness and drug resistance via metabolic pathway modulation. Cancers (Basel). 2025;17:1469.","journal-title":"Cancers (Basel)"},{"key":"3454_CR16","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1158\/0008-5472.CAN-11-3062","volume":"72","author":"S Nishizawa","year":"2012","unstructured":"Nishizawa S, Hirohashi Y, Torigoe T, Takahashi A, Tamura Y, Mori T, et al. HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells. Cancer Res. 2012;72:2844\u201354.","journal-title":"Cancer Res"},{"key":"3454_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","volume":"80","author":"D Firth","year":"1993","unstructured":"Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80:27\u201338.","journal-title":"Biometrika"},{"key":"3454_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.0006-341X.2001.00114.x","volume":"57","author":"G Heinze","year":"2001","unstructured":"Heinze G, Schemper M. A solution to the problem of monotone likelihood in Cox regression. Biometrics. 2001;57:114\u20139.","journal-title":"Biometrics"},{"key":"3454_CR19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/tan.12113","volume":"81","author":"R Yamada","year":"2013","unstructured":"Yamada R, Takahashi A, Torigoe T, Morita R, Tamura Y, Tsukahara T, et al. Preferential expression of cancer\/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer\/testis\/stem gene: Cancer\/testis\/stem genes. Tissue Antigens. 2013;81:428\u201334.","journal-title":"Tissue Antigens"},{"key":"3454_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41419-022-04599-x","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang Z, Li Y, Mao R, Zhang Y, Wen J, Liu Q, et al. DNAJB8 in small extracellular vesicles promotes Oxaliplatin resistance through TP53\/MDR1 pathway in colon cancer. Cell Death Dis. 2022;13:151.","journal-title":"Cell Death Dis"},{"key":"3454_CR21","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1158\/1078-0432.CCR-11-2527","volume":"18","author":"A Mang\u00e9","year":"2012","unstructured":"Mang\u00e9 A, Lacombe J, Bascoul-Mollevi C, Jarlier M, Lamy P-J, Rouanet P, et al. Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer. Clin Cancer Res. 2012;18:1992\u20132000.","journal-title":"Clin Cancer Res"},{"key":"3454_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/CBM-201497","volume":"30","author":"M Sirotkovi\u0107-Skerlev","year":"2021","unstructured":"Sirotkovi\u0107-Skerlev M, Plaveti\u0107 ND, Sedli\u0107 F, Kuna SK, Vrbanec D, Belev B, et al. Prognostic value of circulating Bcl-2 and anti-p53 antibodies in patients with breast cancer: A long term follow-up (17.5 years). Cancer Biomark. 2021;30:95\u2013104.","journal-title":"Cancer Biomark"},{"issue":"Suppl 1","key":"3454_CR23","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1007\/s10875-012-9768-y","volume":"33","author":"T Rath","year":"2013","unstructured":"Rath T, Kuo TT, Baker K, Qiao S-W, Kobayashi K, Yoshida M, et al. The immunologic functions of the neonatal Fc receptor for IgG. J Clin Immunol. 2013;33(Suppl 1):S9\u201317.","journal-title":"J Clin Immunol"},{"key":"3454_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2288-8-52","volume":"8","author":"T Ostermann","year":"2008","unstructured":"Ostermann T, Willich SN, L\u00fcdtke R. Regression toward the mean\u2013a detection method for unknown population mean based on Mee and Chua\u2019s algorithm. BMC Med Res Methodol. 2008;8:52.","journal-title":"BMC Med Res Methodol"},{"key":"3454_CR25","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1158\/1078-0432.CCR-08-1479","volume":"15","author":"T Tanei","year":"2009","unstructured":"Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res. 2009;15:4234\u201341.","journal-title":"Clin Cancer Res"},{"key":"3454_CR26","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3390\/ijms22041808","volume":"22","author":"J Strietz","year":"2021","unstructured":"Strietz J, Stepputtis SS, Follo M, Bronsert P, Stickeler E, Maurer J. Human primary breast cancer stem cells are characterized by epithelial-mesenchymal plasticity. Int J Mol Sci. 2021;22:1808.","journal-title":"Int J Mol Sci"},{"key":"3454_CR27","doi-asserted-by":"publisher","first-page":"103041","DOI":"10.1016\/j.autrev.2022.103041","volume":"21","author":"D Sexauer","year":"2022","unstructured":"Sexauer D, Gray E, Zaenker P. Tumour- associated autoantibodies as prognostic cancer biomarkers- a review. Autoimmun Rev. 2022;21:103041.","journal-title":"Autoimmun Rev"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03454-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-026-03454-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03454-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:16:09Z","timestamp":1786022169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-026-03454-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":27,"alternative-id":["3454"],"URL":"https:\/\/doi.org\/10.1007\/s00595-026-03454-2","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Sapporo Medical University Hospital (approval no. 322\u2009\u2212\u2009105; \u201cObservational study on breast cancer detection performance using autoantibodies against cancer stem cell antigens\u201d). The study was approved on August 13, 2020. Written informed consent was obtained from all the participants. Blood samples were collected as minimally invasive biospecimens and stored for approved research purposes. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}